Literature DB >> 8601625

Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.

L Voisin1, D Breuillé, L Combaret, C Pouyet, D Taillandier, E Aurousseau, C Obled, D Attaix.   

Abstract

We studied the alterations in skeletal muscle protein breakdown in long lasting sepsis using a rat model that reproduces a sustained and reversible catabolic state, as observed in humans. Rats were injected intravenously with live Escherichia coli; control rats were pair-fed to the intake of infected rats. Rats were studied in an acute septic phase (day 2 postinfection), in a chronic septic phase (day 6), and in a late septic phase (day 10). The importance of the lysosomal, Ca2+ -dependent, and ubiquitin-proteasome proteolytic processes was investigated using proteolytic inhibitors in incubated epitrochlearis muscles and by measuring mRNA levels for critical components of these pathways. Protein breakdown was elevated during the acute and chronic septic phases (when significant muscle wasting occurred) and returned to control values in the late septic phase (when wasting was stopped). A nonlysosomal and Ca2+ -independent process accounted for the enhanced proteolysis, and only mRNA levels for ubiquitin and subunits of the 20 S proteasome, the proteolytic core of the 26 S proteasome that degrades ubiquitin conjugates, paralleled the increased and decreased rates of proteolysis throughout. However, increased mRNA levels for the 14-kD ubiquitin conjugating enzyme E2, involved in substrate ubiquitylation, and for cathepsin B and m-calpain were observed in chronic sepsis. These data clearly support a major role for the ubiquitin-proteasome dependent proteolytic process during sepsis but also suggest that the activation of lysosomal and Ca2+ -dependent proteolysis may be important in the chronic phase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601625      PMCID: PMC507224          DOI: 10.1172/JCI118586

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

2.  cDNA cloning and sequencing of component C8 of proteasomes from rat hepatoma cells.

Authors:  K Tanaka; H Kanayama; T Tamura; D H Lee; A Kumatori; T Fujiwara; A Ichihara; F Tokunaga; R Aruga; S Iwanaga
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

Review 3.  Regulation of ATP-ubiquitin-dependent proteolysis in muscle wasting.

Authors:  D Attaix; D Taillandier; S Temparis; D Larbaud; E Aurousseau; L Combaret; L Voisin
Journal:  Reprod Nutr Dev       Date:  1994

Review 4.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

5.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

6.  Influence of sepsis in rats on muscle protein turnover in vivo and in tissue incubated under different in vitro conditions.

Authors:  M Hall-Angerås; U Angerås; D von Allmen; T Higashiguchi; O Zamir; P O Hasselgren; J E Fischer
Journal:  Metabolism       Date:  1991-03       Impact factor: 8.694

7.  Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.

Authors:  K Furuno; M N Goodman; A L Goldberg
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

8.  Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.

Authors:  S Temparis; M Asensi; D Taillandier; E Aurousseau; D Larbaud; A Obled; D Béchet; M Ferrara; J M Estrela; D Attaix
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Molecular cloning, expression and characterization of a ubiquitin conjugation enzyme (E2(17)kB) highly expressed in rat testis.

Authors:  S S Wing; P Jain
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

10.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.

Authors:  G Tiao; J M Fagan; N Samuels; J H James; K Hudson; M Lieberman; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

View more
  44 in total

1.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Inhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover.

Authors:  Stephen Bertsch; Charles H Lang; Thomas C Vary
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

Review 3.  Expression of subunits of the 19S complex and of the PA28 activator in rat skeletal muscle.

Authors:  D Attaix; D Taillandier; L Combaret; C Rallière; D Larbaud; E Aurousseau; K Tanaka
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

4.  Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.

Authors:  Anthony J Kee; Lydie Combaret; Thomas Tilignac; Bertrand Souweine; Eveline Aurousseau; Michel Dalle; Daniel Taillandier; Didier Attaix
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

5.  Tissue distribution of the "N-end rule" ubiquitin-conjugating enzyme, HR6, in the rat.

Authors:  Andre Tomasino; Lars Klimaschewski
Journal:  Histochem Cell Biol       Date:  2005-05-03       Impact factor: 4.304

6.  Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.

Authors:  N E Tawa; R Odessey; A L Goldberg
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 7.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

8.  Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse.

Authors:  James G Tidball; Melissa J Spencer
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 9.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

10.  Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers.

Authors:  Christiane G Frick; Heidrun Fink; Maria L Gordan; Barbara Eckel; J A Jeevendra Martyn; Manfred Blobner
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.